Associations of the Gut Microbiome With Treatment Resistance in Schizophrenia/Experiment 3

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-7-16

Curated date: 2024/06/29

Curator: Jacob A. De Jesus

Revision editor(s): Jacob A. De Jesus, Scholastica, WikiWorks

Subjects

Location of subjects
Australia
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Treatment refractory schizophrenia refractory schizophrenia,treatment resistant schizophrenia,treatment-refractory schizophrenia,TRS,Treatment refractory schizophrenia,treatment refractory schizophrenia
Group 0 name Corresponds to the control (unexposed) group for case-control studies
AAP: individuals with treatment-responsive schizophrenia taking atypical antipsychotics (not clozapine)
Group 1 name Corresponds to the case (exposed) group for case-control studies
TRS: individuals with treatment-resistant schizophrenia taking clozapine
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants with treatment-resistant schizophrenia categorized as follows: 1. CR: individuals with treatment-resistant schizophrenia who were clozapine responsive total PANSS score ≤60). 2. CNR: individuals with treatment-resistant schizophrenia who were clozapine nonresponsive (total PANSS score >60).
Group 0 sample size Number of subjects in the control (unexposed) group
24
Group 1 sample size Number of subjects in the case (exposed) group
48
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
2 months

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
centered log-ratio
Statistical test
ANCOM
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Matched on Factors on which subjects have been matched on in a case-control study
age, body mass index, sex
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
age, body mass index, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-7-16

Curated date: 2024/07/01

Curator: Jacob A. De Jesus

Revision editor(s): Jacob A. De Jesus, WikiWorks

Source: Figure 3

Description: Differentially abundant species identified for AAP and TRS group comparisons. Analyses were performed using ANCOM-BC, adjusting for age, sex, and body mass index.

Abundance in Group 1: increased abundance in TRS: individuals with treatment-resistant schizophrenia taking clozapine

NCBI Quality ControlLinks
Eggerthella lenta
Eisenbergiella tayi
Hungatella effluvii
Ruthenibacterium lactatiformans
Faecalicatena gnavusFaecalicatena gnavus
Negativibacillus sp000435195Negativibacillus sp000435195
Tyzzerella sp000411335Tyzzerella sp000411335
Absiella innocuumAbsiella innocuum
Lachnospiraceae MIC9747Lachnospiraceae MIC9747
Clostridium Q symbiosumClostridium Q symbiosum
QAND01 MIC7514QAND01 MIC7514

Revision editor(s): Jacob A. De Jesus, WikiWorks

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-7-16

Curated date: 2024/07/01

Curator: Jacob A. De Jesus

Revision editor(s): Jacob A. De Jesus, WikiWorks

Source: Figure 3

Description: Differentially abundant species identified for AAP and TRS group comparisons. Analyses were performed using ANCOM-BC, adjusting for age, sex, and body mass index.

Abundance in Group 1: decreased abundance in TRS: individuals with treatment-resistant schizophrenia taking clozapine

NCBI Quality ControlLinks
Faecalibacterium MIC7145Faecalibacterium MIC7145
Faecalibacterium prausnitzii DFaecalibacterium prausnitzii D

Revision editor(s): Jacob A. De Jesus, WikiWorks